Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 297-299

  Pal, Nishith Kumar ^a   Mandal, Shyamapada ^a   Mandal, Manisha Deb ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Ciprofloxacin; MIC; S. Typhi; Zone diameter of inhibition

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; DRUG EFFECT; HUMAN; INDIA; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SALMONELLA TYPHI; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 4344711667     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.025     Document Type: Article

References (13)

1. Ramirez C.A., Bran J.L., Meija C.R., Gracia J.F. Open prospective study of the clinical efficacy of ciprofloxacin. Antimicrob. Agents Chemother. 28:1985;128-132
2. Mandal S., Deb Mandal M., Pal N.K. Antibiotic resistance pattern of Salmonella typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn. J. Infect. Dis. 55:2002;58-59
3. Mandal S., Deb Mandal M., Pal N.K. R-factor in Salmonella enterica serovar Typhi: transfer to and acquisition from Escherichia coli. Jpn. J. Infect. Dis. 56:2003;65-67
4. Jesudasan M.V., Malathy B., John T.J. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J. Med. Res. 103:1996;247-249
5. Threlfal E.J., ward L.R., Skinner J.A., Smith H.R., Laceys S. Ciprofloxacin resistant Salmonella typhi and treatment failure. Lancet. 353:1999;1590-1591
6. Murdoch D.H., Banatvala N.A., Bone A., Shoismatulloev B.I., Ward L.R., Threlfall E.J. Epidemic ciprofloxacin resistant Salmonella typhi in Tajikistan. Lancet. 351:1998;339
7. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A4. Wayne, PA: NCCLS, 1997.
8. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Wayne, PA: NCCLS, 1997.
9. Chandel D.S., Chaudhury R. Enteric fever treatment failures: a global concern. Emerg. Infect. Dis. 7:2001;762-763
10. Threlfall E.J., Ward L.R. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg. Infect. Dis. 7:2001;48-50
11. Chinh N.T., Parry C.M., Ly N.T., et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug resistant or nalidixic resistant enteric fever. Antimicrob. Agents Chemother. 44:2000;1855-1859
12. Wain J., Hoa N.T.T., Chinh N.T., et al. Quinolone-resistance Salmonelle typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25:1997;1404-1410
13. Aarestrup F.M., Wiuff C., Mølbak K., Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:2003;827-829